XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:    
Net loss $ (32,386) $ (44,399)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 2,142 2,876
Depreciation and amortization 9,946 8,599
Non-cash interest expense on finance obligations 601 546
Unrealized (gain) loss on derivative contracts (2,700) 5,387
Operating lease costs 333 355
Operating lease payments (328) (244)
Unrealized foreign currency losses   59
Other, net 60 11
Decrease (increase) in operating assets:    
Accounts receivable 2,509 463
Unbilled receivables (697) (3,048)
Inventories (14,200) (18,403)
Other assets (2,000) (1,616)
(Decrease) increase in operating liabilities:    
Accounts payable (3,334) (6,027)
Accrued liabilities (6,689) (3,990)
Deferred revenue 1,033 1,164
Net cash used in operating activities (45,710) (58,267)
Cash flows from investing activities:    
Capital expenditures (7,060) (10,565)
Project asset expenditures (310) (7,520)
Maturity of held-to-maturity debt securities 378,930 230,375
Purchases of held-to-maturity debt securities (378,915) (125,397)
Net cash (used in) provided by investing activities (7,355) 86,893
Cash flows from financing activities:    
Repayment of debt and finance obligations (3,037) (2,595)
Payment for deferred financing costs (152)  
Common stock issued for stock plans and related expenses 16 68
Contributions received from sale of noncontrolling interest, net of return of capital 4,000 25,122
Distribution to noncontrolling interest (600) (236)
Payments for taxes related to net share settlement of equity awards (483) (995)
Common stock issuance, net of fees 5,892  
Payment of preferred dividends (800) (800)
Net cash provided by financing activities 4,836 20,564
Effects on cash from changes in foreign currency rates (232) 33
Net (decrease) increase in cash, cash equivalents and restricted cash (48,461) 49,223
Cash, cash equivalents and restricted cash-beginning of period 208,883 299,576
Cash, cash equivalents and restricted cash-end of period $ 160,422 $ 348,799